Metagenomi Therapeutics (MGX) Earnings Date & Reports

Metagenomi Therapeutics Inc is an vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MGX is expected to report earnings to rise 45.90% to -88 cents per share on November 18

Metagenomi Therapeutics MGX Stock Earnings Reports

Q3'26

Est.

$-0.89

Q1'26

Beat

by $0.17

Q4'25

Beat

by $0.22

Q3'25

Beat

by $0.25

Q2'25

Beat

by $0.18

The last earnings report on May 11 showed earnings per share of -61 cents, beating the estimate of -77 cents. With 267.46K shares outstanding, the current market capitalization sits at 46.47M.

View a ticker or compare two or three

MGX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days